Boston Scientific Corp. (NYSE: BSX) Q4 2020 earnings call dated Feb. 03, 2021
Corporate Participants:
Susie Lisa — Vice President, Investor Relations
Michael F. Mahoney — Chairman and Chief Executive Officer
Daniel J. Brennan — Executive Vice President and Chief Financial Officer
Kenneth Stein — Senior Vice President and Chief Medical Officer, CRM
Analysts:
Robert A. Hopkins — Bank of America Merrill Lynch — Analyst
David Ryan Lewis — Morgan Stanley — Analyst
Lawrence Biegelsen — Wells Fargo Securities — Analyst
Joanne Wuensch — Citi — Analyst
Robert Marcus — J.P. Morgan — Analyst
Matthew Taylor — UBS — Analyst
_________
To read the full earnings call transcript, click here
Most Popular
Infographic: How Alaska Air Group (ALK) performed in Q1 2024
Alaska Air Group (NYSE: ALK) reported its first quarter 2024 earnings results today. Total operating revenue increased 2% year-over-year to $2.23 billion. Net loss amounted to $132 million, or $1.05 per
KMI Earnings: Kinder Morgan Q1 2024 adjusted profit increases; revenue drops
Kinder Morgan, Inc. (NYSE: KMI) reported higher adjusted earnings for the first quarter of 2024 despite a decrease in revenues. The energy infrastructure company also issued guidance for the full
What to expect when Altria (MO) reports first quarter 2024 earnings results
Shares of Altria Group, Inc. (NYSE: MO) stayed green on Wednesday. The stock has dropped 8% over the past one month. The tobacco giant is scheduled to report its first
Listen On
